Colaborador de la División de Coordinación, Evaluación y Seguimiento Científico y Técnico.
Gestor del área científica: Biomedicina (BME).
Subárea: Cáncer (CAN).
Lugar de Trabajo: Instituto de Biomedicina de Sevilla / Hospital Universitario Virgen del Rocío / Universidad de Sevilla.
Enrique de Álava M.D., PhD. (Pamplona, Spain, 1964) is, since 2013, the Chairman,Department of Pathology at the University Hospital Virgen del Rocio, Principal Investigator at the Seville Institute of Biomedicine, scientific coordinator of the Campus Biobank, and Professor of Pathology of the University of Seville.
He obtained a degree in Medicine and Surgery at the University of Navarra (UN)
in 1988, finishing his training as a specialist in Pathology in 1993 at the UN. He got a PhD in Medicine and Surgery from the UN (1993). He completed his postdoctoral training in the Department of Pathology at Memorial Sloan Kettering Cancer Center in New York, from 1994 to 1996, thanks to a postdoctoral fellowship from the Spanish Ministry of Education and Science. He become a tenured research scientist of the Spanish Research Council (CSIC) in 2003 and became a Principal Investigator of the Laboratory of Molecular Pathology at the Cancer Research Center of Salamanca, Spain. In 2009 he was promoted to CSIC Full Research Professor.
He is a Pathologist with special interest in Bone and soft tissue Pathology, and in Diagnostic Molecular Pathology, with a focus on sarcoma translational research. His main research focus is translational research of sarcomas. His research objectives are
the search and validation of new therapeutic targets, mechanisms of sarcomagenesis and
validation of new tools directly applicable to the hospital diagnostic routine.
He is strongly committed to dissemination of cancer research to patients, patient organisations, and High School students. He is very active in social media networks under @EnriquedeAlava.